Alistair Macdonald brings over 30 years of biopharmaceutical and life sciences leadership experience to Envision Pharma Group's Board of Directors

阿利斯泰尔·麦克唐纳（AlistairMacDonald）为Envision Pharma Group董事会带来了30多年的生物制药和生命科学领导经验

FAIRFIELD, CT / ACCESSWIRE / May 8, 2024 / Envision Pharma Group (Envision) announced today the appointment of Alistair Macdonald to the Envision Board of Directors.

康涅狄格州费尔菲尔德/ACCESSWIRE/2024年5月8日/Envision Pharma Group（Envision）今天宣布任命阿利斯泰尔·麦克唐纳为Envision董事会成员。

'It's a pleasure to welcome Alistair to the Envision Board of Directors,' shared Howard Miller, CEO of Envision Pharma Group. 'His deep knowledge of executive and operational functions across manufacturing, consulting, clinical and commercial sectors aligns perfectly with the services we offer our clients.

Envision制药集团首席执行官霍华德·米勒（HowardMiller）表示，很高兴欢迎阿利斯泰尔加入Envision董事会他对制造、咨询、临床和商业部门的执行和运营职能有着深刻的了解，这与我们为客户提供的服务完全吻合。

His leadership on the board will position us to continue driving improved outcomes and insights for the life sciences industry.'.

他在董事会的领导地位将使我们能够继续推动生命科学行业取得更好的成果和见解。”。

Alistair Macdonald brings over 30 years of biopharmaceutical and life sciences experience in executive and operation roles across manufacturing, consulting, clinical and commercial sectors and currently serves as an operating partner for BHO Capital. Most recently, he served as the Chief Executive Officer for Syneos Health, a global CRO with over 29,000 employees and operations in over 100 countries.

阿利斯泰尔·麦克唐纳（AlistairMacdonald）在制造业、咨询业、临床和商业部门的执行和运营方面拥有30多年的生物制药和生命科学经验，目前是必和必拓资本（BHO Capital）的运营合作伙伴。最近，他担任Syneos Health的首席执行官，Syneos Health是一家全球CRO，在100多个国家拥有29000多名员工和业务。

Before becoming CEO, Alistair held several leadership roles across the company, including clinical development, global oncology, business development & alliance management to drive operational excellence..

在成为首席执行官之前，Alistair曾在公司担任多个领导职务，包括临床开发、全球肿瘤学、业务开发和联盟管理，以推动卓越运营。。

Prior to his time at Syneos, Alistair's career is marked by increasing responsibility and leadership positions at Bovis Lendlease Consulting, supporting companies worldwide, and technical and production management positions at Novartis. He began his career in a dynamic CDMO operation with CCL Pharmaceuticals..

在加入Syneos之前，Alistair的职业生涯是在Bovis Lendlease Consulting、全球支持公司以及诺华技术和生产管理职位上增加责任和领导职位。他的职业生涯始于CCL Pharmaceuticals的动态CDMO运营。。

Macdonald will bring a wealth of board leadership experience with this new appointment, as he currently serves as a board member for the Medicines Discovery Catapult Foundation. Previously, he was the director and chairman of the Association of Clinical Research Organizations Board of Directors and a member of Syneos Health's Board of Directors..

麦克唐纳将在这次新任命中带来丰富的董事会领导经验，因为他目前是药物发现弹射器基金会的董事会成员。此前，他曾任临床研究组织协会董事会董事兼主席，Syneos Health董事会成员。。

'As a long-time admirer of Envision Pharma Group's business model, it's an honour to help them drive the strongest value proposition possible for its customers. I look forward to drawing on my industry and leadership experience in this role to support the crucial work Envision is doing in the life sciences space,' says Alistair Macdonald..

“作为Envision Pharma Group商业模式的长期仰慕者，很荣幸能帮助他们为客户创造尽可能强大的价值主张。阿利斯泰尔·麦克唐纳（AlistairMacDonald）说：“我期待着利用我在这个职位上的行业和领导经验，支持Envision在生命科学领域所做的关键工作。”。。

About Envision Pharma Group

关于Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions.

Envision Pharma Group成立于2001年，是生命科学行业领先的全球技术支持战略解决方案合作伙伴，与200多家制药和生物技术公司合作，其中包括前20家制药公司中的18家。Envision通过一套全面的服务和业界领先的技术解决方案，在整个产品生命周期中为客户提供支持，这些解决方案包括人工智能和自然语言处理、商业化和综合战略咨询、循证科学通信和参与、HEOR/市场准入和数据分析、医疗能力以及全渠道解决方案。

Learn more at www.envisionpharmagroup.com..

Learn more at www.envisionpharmagroup.com..

Contact Information:

联系方式：

Annie Downing Downing

安妮·唐宁

VP, Global Head of Marketing, PR & Communications

营销、公关和传播全球总监副总裁

anne.downing@envisionpharma.com

anne.downing@envisionpharma.com

SOURCE: Envision Pharma Group

来源：Envision Pharma Group

View the original press release on newswire.com.

在newswire.com上查看原始新闻稿。